Park Medi World (Park Hospitals) IPO
Park Medi World Ltd. is launching a book-built IPO of Rs. 920 crore, comprising a fresh issue of Rs. 770 crore and an offer for sale of Rs. 150 crore.
The IPO opens on December 10, 2025, and closes on December 12, 2025. The allotment is expected on December 15, 2025, and the listing is tentatively scheduled for December 17, 2025 on BSE and NSE.
The price band is Rs. 154 to Rs. 162 per share, and the lot size is 92 shares.
🕗 Last Update: 5 December 2025
👉 GMP | Reviews | Subscription | Allotment
👉 Chanakya Grey Market Intelligence – 8 PM Edition | News Crux |
👉 Power Calls | Breakout Stocks | Coffee Can Portfolio |
IPO Key Dates
| Event | Date |
|---|---|
| IPO Opens | Wednesday, December 10, 2025 |
| IPO Closes | Friday, December 12, 2025 |
| Allotment Finalisation | Monday, December 15, 2025 |
| Refund Initiation | Tuesday, December 16, 2025 |
| Shares to Demat | Tuesday, December 16, 2025 |
| Listing Date | Wednesday, December 17, 2025 |
| UPI Cut-off | 5 PM on Friday, December 12, 2025 |
IPO Details
| Particulars | Details |
|---|---|
| Face Value | Rs. 2 per share |
| Issue Price Band | Rs. 154 to Rs. 162 per share |
| Lot Size | 92 shares |
| Sale Type | Fresh Issue + Offer for Sale |
| Total Issue Size | Rs. 920 Cr |
| Fresh Issue | Rs. 770 Cr |
| Offer for Sale | Rs. 150 Cr |
| Issue Type | Book-built IPO |
| Listing At | BSE & NSE |
| Retail Allocation | 35% |
| Shareholding Pre-Issue | 38,44,00,000 shares |
| Shareholding Post-Issue | — (to be updated after final RHP) |
Reservation Structure
| Investor Category | Allocation |
|---|---|
| QIB | Not more than 50% |
| Retail | Not less than 35% |
| NII (HNI) | Not less than 15% |
Promoter Holding
| Particulars | Percentage |
|---|---|
| Pre-Issue | 99.16% |
| Post-Issue | — |
Promoters: Dr. Ajit Gupta and Dr. Ankit Gupta
About Park Medi World Ltd.
Incorporated in 2011, Park Medi World is one of North India’s largest private hospital networks, with 3,000 beds across 13 multi-super speciality hospitals under the Park Hospitals brand.
All hospitals are NABH-accredited, and seven hold NABL accreditation.
Park provides over 30 speciality and super-speciality services, including neurology, oncology, orthopaedics, general surgery, internal medicine, gastroenterology and more.
Infrastructure footprint:
-
805 ICU beds
-
63 Operating Theatres
-
2 dedicated cancer centres
-
Oxygen-generation plants at all hospitals
Hospital locations span Haryana, Delhi, Punjab and Rajasthan, including Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad, Mohali, Patiala, Jaipur and Behror.
Workforce (as of Sept 30, 2024):
-
891 doctors
-
1,912 nurses
-
671 medical professionals
-
1,761 support staff
Competitive Strengths
-
Second-largest private hospital chain in North India
-
Largest private hospital network in Haryana
-
Strong patient volume and diversified speciality mix
-
Consistent acquisition and integration track record
-
Strong financial performance with stable margins
-
Doctor-led, professionally managed organisation
Financials (Rs. crore)
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 2,018.74 | 1,912.10 | 1,592.83 | 1,293.23 |
| Total Income | 707.45 | 1,263.08 | 1,272.18 | 1,093.96 |
| PAT | 112.89 | 152.01 | 228.19 | 199.38 |
| EBITDA | 189.62 | 310.30 | 390.34 | 343.71 |
| Net Worth | — | 815.98 | 667.55 | 437.77 |
| Borrowings | 648.96 | 686.71 | 575.68 | 517.42 |
Key Performance Indicators
| KPI | Value |
|---|---|
| ROE | 18.25% |
| ROCE | 16.07% |
| Debt/Equity | 0.73 |
| RoNW | 18.81% |
| PAT Margin | 12.35% |
| EBITDA Margin | 25.21% |
Objects of the Issue
| S. No. | Use of Proceeds | Amount (Rs. Million) |
|---|---|---|
| 1 | Partial or full repayment of borrowings | 4,100 |
| 2 | Capex for new hospital + expansion | 1,100 |
| 3 | Purchase of medical equipment | 771.86 |
| 4 | Inorganic acquisitions & general corporate purposes | — |
Company Contact
Park Medi World Ltd.
12, Meera Enclave, Near Keshopur Bus Depot
Outer Ring Road, New Delhi – 110018
📞 +91 124 696 000
✉ company.secretary@parkhospital.in
🌐 www.parkhospital.in
Lead Managers
Nuvama Wealth Management Ltd.
CLSA India Pvt. Ltd.
Dam Capital Advisors Ltd.
Intensive Fiscal Services Pvt. Ltd.
Registrar
Kfin Technologies Ltd.
📞 040-67162222 / 040-79611000
✉ parkmedi.ipo@kfintech.com
🌐 https://ipostatus.kfintech.com/
Chanakya IPO Review – By Paresh Gordhandas, CA & Research Analyst
1. Business Overview
Park Medi World is positioned as one of North India’s largest hospital chains, with a robust 3,000-bed network and 805 ICU beds—indicating high clinical capacity. Strong brand positioning across Haryana and Delhi-NCR provides sustained patient volumes and operational leverage.
2. Financial Performance
The company demonstrates consistent top-line performance, with FY22–FY24 revenue holding above Rs. 1,250 crore.
EBITDA margin (25%+) and PAT margin (12%+) reflect operational efficiency typical of scaled healthcare institutions.
Borrowings remain manageable given the company’s expansion needs.
3. Valuation View
At a price band of Rs. 154–162, the valuations appear competitive for a mid-size private healthcare chain. With growing demand for organised hospital operators and the company’s expansion-focused deployment of IPO proceeds, medium- to long-term prospects strengthen.
4. Risks
-
Execution risks in new hospital expansion
-
Competitive pressure from larger listed peers
-
Sensitivity to regulatory pricing and payor mix
5. Chanakya Verdict
Park Medi World offers a compelling blend of scale, operational strength, and expansion visibility. Investors seeking exposure to the healthcare sector may consider subscribing for long-term value.
Listing gains possible depending on institutional response and market sentiment.
Quicklinks
- Market Analysis by Nagaraj Shetti
- Stock Market today by Vaishali Parekh
- Analysis by Kotak Securities
- Market Analysis by HDFC Securities
- Technical Analysis by Kotak Securities
- Technical Analysis by Samco Securities
- Reliance, Target & Stoploss
- Gold Analysis
- FII buy-Sell
- Technical Analysis
- Calls for the Day
- Currency Analysis
Disclaimer
This coverage is for informational and educational purposes. Chanakya Ni Pothi does not deal in Grey Market Premiums or recommend investments based on GMP data. Please consult your SEBI-registered investment advisor.
